Anti-TBRG1 Antibody

Produced in rabbit and raised against recombinant human TBRG1, this polyclonal IgG reagent from Antibodies.com is supplied at 50 µl and validated for Western blot detection of endogenous protein in human samples.

TBRG1 (Transforming Growth Factor Beta Regulator 1, also termed NIAMS) is a nucleolar factor implicated in cell-cycle progression, mitotic checkpoint control, and apoptosis regulation, with published links to transforming growth factor-beta signaling. The unconjugated primary antibody is applied in studies probing TBRG1 expression and turnover across cancer cell lines, tumor tissue lysates, and gene-knockdown or overexpression models.

Researchers investigating hepatocellular carcinoma, breast tumor biology, and DNA-damage response pathways use the reagent to monitor endogenous TBRG1 levels following siRNA, CRISPR/Cas9 editing, or drug treatment. Each lot is affinity-purified and supplied in a stabilizing buffer for standard immunoblotting workflows, with recommended storage at -20 °C in single-use aliquots to preserve reactivity across multiple experiments.